A telescopic implant that fits directly into the eye to treat certain kinds of blindness has finally received FDA approval for use in the US after more than five years of waiting. The Implantable Miniature Telescope (IMT) is used to treat age-related macular degeneration(AMD), a condition that affects millions around the world. For many, the center part of their vision becomes blurred or completely dark. The IMT is surgically implanted into the cornea and acts to expand an incoming image onto the peripheral parts of the retina that are undamaged by AMD. More than two-thirds of those treated enjoy significantly improved vision. The commercial version of the IMT is called CentraSight and is in development by VisionCare Inc. There are likely hundreds of thousands of potential patients in the US alone who may be able to have their vision partially restored now that CentraSight has garnered FDA approval.
Implantable Eye Telescope That Treats AMD Now FDA Approved